XML 235 R117.htm IDEA: XBRL DOCUMENT v3.20.1
Equity-Accounted Investees - Other equity method investees - Ownership and Carrying Amount (Details) - EUR (€)
€ in Thousands
1 Months Ended 12 Months Ended
Oct. 22, 2018
May 17, 2016
Feb. 28, 2019
Dec. 31, 2019
Dec. 31, 2018
Jan. 01, 2019
Dec. 31, 2017
Dec. 31, 2016
Disclosure of associates [line items]                
Investments in equity-accounted investees       € 114,473 € 226,905   € 219,009  
Rest of equity accounted investees                
Disclosure of associates [line items]                
Investments in equity-accounted investees         79,616 € 79,616    
Investments in equity-accounted investees       € 54,183 € 226,905   219,009 € 201,345
Alkahest, Inc.                
Disclosure of associates [line items]                
Ownership interest (as a percent)       47.58% 47.58%      
Investments in equity-accounted investees       € 14,708 € 28,336      
Albajuna Therapeutics, S.L.                
Disclosure of associates [line items]                
Ownership interest (as a percent)       49.00% 30.00%      
Investments in equity-accounted investees       € 5,228 € 1,106      
Singulex, Inc.                
Disclosure of associates [line items]                
Ownership interest (as a percent)   19.33%   0.00% 19.33%      
Investments in equity-accounted investees         € 19,256   29,322  
GigaGen, Inc                
Disclosure of associates [line items]                
Ownership interest (as a percent)       43.96% 43.96%      
Investments in equity-accounted investees       € 23,997 € 28,363   € 29,047  
Mecwins, S.A                
Disclosure of associates [line items]                
Ownership interest (as a percent) 24.99%     24.99% 24.99%      
Investments in equity-accounted investees       € 2,338 € 2,555      
Medcom Advance, S.A.                
Disclosure of associates [line items]                
Ownership interest (as a percent)     45.00% 45.00%        
Investments in equity-accounted investees       € 7,912